Inhibition of interleukin-8 synthesis by intraarticular methotrexate therapy in patientes with rheumatoid arthritis

5 Patients with definite RA and knee effusions under constant doses of DMARD therapy were treated with up to 6 intraarticular injections of 10mg methotrexate (MTX) every 3 to 7 days. A matched randomized control group who received a single i.a. injection of 40mg triamcinolone hexacetonide (TC) was m...

Full description

Saved in:
Bibliographic Details
Main Authors: Gao, Ino K. (Author) , Leins, C. (Author) , Bohlen, H. (Author) , Heilig, Bernhard (Author) , Lemmel, E.-M. (Author)
Format: Article (Journal)
Language:English
Published: April 1998
In: Zeitschrift für Rheumatologie
Year: 1998, Volume: 57, Issue: 2, Pages: 95-100
ISSN:1435-1250
DOI:10.1007/s003930050066
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s003930050066
Get full text
Author Notes:I.K. Gao, C. Leins, H. Bohlen, B. Heilig, E.-M. Lemmel
Description
Summary:5 Patients with definite RA and knee effusions under constant doses of DMARD therapy were treated with up to 6 intraarticular injections of 10mg methotrexate (MTX) every 3 to 7 days. A matched randomized control group who received a single i.a. injection of 40mg triamcinolone hexacetonide (TC) was monitored according to the same protocol. The intraarticular granulocyte counts and IL-8 levels decreased in all MTX treated patients on day 10-13 and stayed low in those patients who could be re-evaluated after 13 weeks. Compared to the IL-8 levels, the other tested cytokine levels showed only minor changes on day 10-13. There was no need for re-injection in the TC group during the 13 week study phase.
Item Description:Zusammenfassung in deutscher und englischer Sprache
Gesehen am 13.08.2025
Physical Description:Online Resource
ISSN:1435-1250
DOI:10.1007/s003930050066